Rosoph L, Ladel L, Patel R, Webster P
Cureus. 2024; 16(4):e58242.
PMID: 38745808
PMC: 11093182.
DOI: 10.7759/cureus.58242.
Ferluga J, Yasmin H, Bhakta S, Kishore U
Adv Exp Med Biol. 2021; 1313:217-240.
PMID: 34661897
DOI: 10.1007/978-3-030-67452-6_10.
Habal M
Front Immunol. 2021; 12:702186.
PMID: 34504489
PMC: 8423343.
DOI: 10.3389/fimmu.2021.702186.
Nath N, Godat B, Flemming R, Urh M
J Immunol. 2021; 207(4):1211-1221.
PMID: 34312257
PMC: 8358922.
DOI: 10.4049/jimmunol.2100181.
Ravindranath M, Hilali F, Filippone E
Vaccines (Basel). 2021; 9(6).
PMID: 34205517
PMC: 8235337.
DOI: 10.3390/vaccines9060680.
Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs.
Dembele M, Tao S, Massoud A, Miah S, Lelias S, De Groot A
Front Immunol. 2021; 12:634509.
PMID: 33953711
PMC: 8089381.
DOI: 10.3389/fimmu.2021.634509.
Current status of potential therapeutic candidates for the COVID-19 crisis.
Zhang J, Xie B, Hashimoto K
Brain Behav Immun. 2020; 87:59-73.
PMID: 32334062
PMC: 7175848.
DOI: 10.1016/j.bbi.2020.04.046.
Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer.
Lewis B, Ville J, Blacquiere M, Cen S, Spirig R, Zuercher A
BMC Immunol. 2019; 20(1):44.
PMID: 31801459
PMC: 6894239.
DOI: 10.1186/s12865-019-0328-6.
GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
Lewis B, Leontyev D, Neschadim A, Blacquiere M, Branch D
Clin Exp Immunol. 2018; 193(3):293-301.
PMID: 29704458
PMC: 6150254.
DOI: 10.1111/cei.13144.
A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus.
Magnani D, Silveira C, Rosen B, Ricciardi M, Pedreno-Lopez N, Gutman M
PLoS Negl Trop Dis. 2017; 11(6):e0005655.
PMID: 28604797
PMC: 5481143.
DOI: 10.1371/journal.pntd.0005655.
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease.
Lobo P
Front Immunol. 2016; 7:198.
PMID: 27375614
PMC: 4893492.
DOI: 10.3389/fimmu.2016.00198.
Suppression of allo-human leucocyte antigen (HLA) antibodies secreted by B memory cells in vitro: intravenous immunoglobulin (IVIg) versus a monoclonal anti-HLA-E IgG that mimics HLA-I reactivities of IVIg.
Zhu D, Ravindranath M, Terasaki P, Miyazaki T, Pham T, Jucaud V
Clin Exp Immunol. 2014; 177(2):464-77.
PMID: 24611451
PMC: 4226597.
DOI: 10.1111/cei.12307.
Normal IgG downregulates the intracellular superoxide level and attenuates migration and permeability in human aortic endothelial cells isolated from a hypertensive patient.
Wang X, Wang Q, Sun Z
Hypertension. 2012; 60(3):818-26.
PMID: 22777940
PMC: 3421057.
DOI: 10.1161/HYPERTENSIONAHA.112.199281.
Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.
Guhr T, Bloem J, Derksen N, Wuhrer M, Koenderman A, Aalberse R
PLoS One. 2011; 6(6):e21246.
PMID: 21731683
PMC: 3121734.
DOI: 10.1371/journal.pone.0021246.
Intravenous immunoglobulin in lupus panniculitis.
Espirito Santo J, Gomes M, Gomes M, Peixoto L, C Pereira S, Acabado A
Clin Rev Allergy Immunol. 2009; 38(2-3):307-18.
PMID: 19557315
DOI: 10.1007/s12016-009-8162-x.
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
Wittstock M, Zettl U
J Neurol. 2006; 253 Suppl 5:V75-9.
PMID: 16998759
DOI: 10.1007/s00415-006-5013-z.
Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.
Leonard S, Pierard I, Michaelsen T, Izui S, Masson P, Coutelier J
Clin Exp Immunol. 2006; 145(1):155-61.
PMID: 16792686
PMC: 1941991.
DOI: 10.1111/j.1365-2249.2006.03117.x.
Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system.
Persson L, Boren J, Nicoletti A, Hansson G, Pekna M
Clin Exp Immunol. 2005; 142(3):441-5.
PMID: 16297155
PMC: 1809548.
DOI: 10.1111/j.1365-2249.2005.02954.x.
Modulation of alloimmune response in vitro by an IgM-enriched immunoglobulin preparation (Pentaglobin).
Nachbaur D, Herold M, Gachter A, Niederwieser D
Immunology. 1998; 94(2):279-83.
PMID: 9741353
PMC: 1364217.
DOI: 10.1046/j.1365-2567.1998.00495.x.
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson G
J Clin Invest. 1998; 102(5):910-8.
PMID: 9727059
PMC: 508956.
DOI: 10.1172/JCI119892.